clinicalintelpulse

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description must carry full burden. It mentions cost per endpoint and 'global coverage' but lacks disclosure of idempotency, side effects, error behaviors, authentication requirements, or rate limits. The behavioral insight is minimal.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is lengthy and includes a bulleted list of endpoints with costs, which is informative but could be more concise. It mixes parameter-like content that is already in the schema. Not front-loaded with the essential purpose; the value is diluted.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given 15 parameters, no output schema, and no annotations, the description is incomplete. It does not explain how parameters interact, what return data looks like, or provide usage examples. The list of endpoints is useful but insufficient for full contextual understanding.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100% but descriptions are minimal (e.g., 'phase', 'status'). The description does not add extra meaning beyond the schema; it repeats action names in a list but fails to elaborate on other parameters. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states 'Pharmaceutical pipeline and clinical trial intelligence API' and lists 10 distinct endpoints, making it obvious what the tool does. While sibling tools are different domains (e.g., alphapulse, discover), the purpose is specific and unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

No explicit guidance on when to use this tool versus alternatives. Sibling tools exist but are not mentioned. The description lists endpoints but does not provide context on which scenario fits which endpoint, nor when not to use the tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.